clinical research funding opportunities

• U.S. Department of Health & Human Services

• Virtual Tour
• Staff Directory
• En Español

You are here

Grants & funding.

The National Institutes of Health is the largest public funder of biomedical research in the world. The NIH invests most of its nearly $48 billion budget in medical research seeking to enhance life and to reduce illness and disability. NIH-funded research has led to breakthroughs and new treatments helping people live longer, healthier lives, and building the research foundation that drives discovery.

three-scientists-goggles-test-tube.jpg

Grants Home Page

NIH’s central resource for grants and funding information.

lab-glassware-with-colorful-liquid-square.jpg

Find Funding

NIH offers funding for many types of grants, contracts, and even programs that help repay loans for researchers.

calendar-page-square.jpg

Grant applications and associated documents (e.g., reference letters) are due by 5:00 PM local time of application organization on the specified due date.

submit-key-red-square.jpg

How to Apply

Instructions for submitting a grant application to NIH and other Public Health Service agencies.

female-researcher-in-lab-square.jpg

As you begin your journey in search of NIH grant funding, learn about the structure of NIH and why it’s important to successfully navigate the grants process.

binder-with-papers-on-office-desk-square.jpg

Policy & Compliance

By accepting a grant award, recipients agree to comply with the requirements in the NIH Grants Policy Statement unless the notice of award states otherwise.

blog-key-blue-square.jpg

Grants News/Blog

News, updates, and blog posts on NIH extramural grant policies, processes, events, and resources.

scientist-flipping-through-report-square.jpg

Explore opportunities at NIH for research and development contract funding.

smiling-female-researcher-square.jpg

Loan Repayment

The NIH Loan Repayment Programs repay up to $50,000 annually of a researcher’s qualified educational debt in return for a commitment to engage in NIH mission-relevant research.

Connect with Us

• More Social Media from NIH

Redirect Notice

Clinical trial-specific funding opportunities.

All applicants proposing clinical trials must submit applications through a notice of funding opportunity (NOFO) that is specifically designated for clinical trials. 

For due dates on or after January 25, 2018, NIH requires all applications involving one or more clinical trials to be submitted through a notice of funding opportunity specifically designated for clinical trials. The purpose of this policy is to improve our ability to identify proposed clinical trials, ensure that key pieces of trial-specific information are submitted with each application, and uniformly apply trial-specific review criteria.

Policy Implementation

Applications and proposals involving clinical trials with due dates on or after January 25, 2018 must be submitted to a notice of funding opportunity (NOFO) or request for proposal (RFP) that explicitly states it will accept clinical trials. Since January 25, 2018, NIH no longer accepts clinical trial applications through previous parent announcements. Remember that NIH supports many types of clinical trials (mechanistic, exploratory/developmental, pilot/feasibility, pragmatic, behavioral, and others), so be sure to read your funding opportunity carefully for specific instructions and considerations. It is also recommended that applicants check the online version of their funding opportunity within 8 weeks before the due date to ensure it is still appropriate for their application.

Check Which Opportunities Allow Clinical Trials

To confirm whether a NOFO allows clinical trials, check the opportunity notice's Title and Section II. Award Information for the following designations:

Notices of funding opportunities that accept clinical trials have specific review criteria to ensure that reviewers appropriately consider clinical trial-related information.

Special Considerations

Basic experimental studies with humans (besh).

These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research .

• All notices of funding opportunities for Basic Experimental Studies with Humans (BESH) are designated as "Required -– Basic Experimental Studies with Humans: Only accepting applications that propose clinical trial(s) that also meet the definition of basic research" in Section II. Award Information.
• These notices of funding opportunities are designated as "Basic Experimental Studies with Humans Required" in the funding opportunity title.
• Participation in notices of funding opportunities for Basic Experimental Studies with Humans will vary by NIH Institute and Center (IC). Many ICs will continue to accept Basic Experimental Studies with Humans through existing notices of funding opportunities that accept clinical trials. However, BESH studies responsive to NOFOs other than designated BESH NOFOs will not have registration and results reporting flexibilities temporarily afforded to those responsive to the designated BESH NOFOs. It is important to check with a Program Officer to determine the most appropriate notice of funding opportunity for your application.
• Funding Opportunity Types by Clinical Trial Allowability
• Basic Experimental Studies Involving Humans (BESH)

Career Development (K) Awards

Career Development awards may support either independent clinical trials or a mentored research training experience , depending on the funding opportunity.

• Notices of funding opportunities that indicate "Independent Clinical Trial Required” in the title and in Section II. Award Information support independent clinical trials conducted by the applicant.
• Career Development applicants proposing to gain mentored training in a clinical trial are instructed to provide details of their contribution to the study in the Research Strategy rather than in the clinical trial specific fields on the PHS Human Subjects and Clinical Trials Information form.
• NIH expects the mentor or individual receiving support for the larger trial to have the overall responsibility of the trial.

Fellowships (F) Awards

The NIH encourages fellows to receive training in clinical research; however, NIH supported fellows are not permitted to conduct a clinical trial independently.

• Fellowship (F) notices of funding opportunities do not include this designation in the funding opportunity title.
• Fellowship applicants proposing to gain mentored training in a clinical trial are instructed to provide details of their contribution to the study in the Research Strategy rather than in the clinical trial specific fields on the PHS Human Subjects and Clinical Trials Information form.
• NIH expects the mentor or individual receiving support for the clinical trial to assume overall responsibility of the trial.

Training (T) Awards

Institutional Training awards do not support clinical trials (with the exception of some D43 and K12 awards).

• Training (T) notices of funding opportunities do not include this designation in the funding opportunity title.
• D43 and K12 notices of funding opportunities are designated as "Clinical Trial Not Allowed" or “Clinical Trial Optional” in the funding opportunity title and Section II. Award Information. These applicants will only be permitted to complete fields for Delayed Onset Studies in the PHS Human Subjects and Clinical Trials Information form.
• Updates to Funding Opportunity Terminology
• Continued Extension of Certain Flexibilities for Prospective Basic Experimental Studies with Human Participants
• Notice of Intent to Publish Parent Funding Opportunities for Basic Experimental Studies with Humans
• Delayed Enforcement and Short-Term Flexibilities for Some Requirements Affecting Prospective Basic Science Studies Involving Human Participants
• Reminder: Policy on Funding Opportunities for Clinical Trials Takes Effect January 25, 2018
• Guide Notice on Clinical Trial Funding Opportunity Policy
• NIH Plans for Clinical Trial Specific Parent R01 and Parent R21 Funding Opportunities

Upcoming Events

• Refer to the Comparison of NOFO Types by Clinical Trial Allowability for help determining which notices of funding opportunity to use.
• Check the Annotated Funding Opportunity for help navigating NIH notices of funding opportunities.
• Decision Tool
• Key Dates & Policy Notices
• Case Studies
• Training & Resources
• Important Terms
• Human Subjects Research
• ClinicalTrials.gov
• Resource on Research Methods
• ClinRegs: international clinical trials regulations
• For NIH Staff

An official website of the United States government

Here’s how you know

Official websites use .gov A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS A lock ( A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

• Heart-Healthy Living
• High Blood Pressure
• Sickle Cell Disease
• Sleep Apnea
• Information & Resources on COVID-19
• The Heart Truth®
• Learn More Breathe Better®
• Blood Diseases & Disorders Education Program
• Publications and Resources
• Clinical Trials
• Blood Disorders and Blood Safety
• Sleep Science and Sleep Disorders
• Lung Diseases
• Health Disparities and Inequities
• Heart and Vascular Diseases
• Precision Medicine Activities
• Obesity, Nutrition, and Physical Activity
• Population and Epidemiology Studies
• Women’s Health
• Research Topics
• All Science A-Z
• Grants and Training Home
• Policies and Guidelines

Funding Opportunities and Contacts

• Training and Career Development
• Email Alerts
• NHLBI in the Press
• Research Features
• Ask a Scientist
• Past Events
• Upcoming Events
• Mission and Strategic Vision
• Divisions, Offices and Centers
• Advisory Committees
• Budget and Legislative Information
• Jobs and Working at the NHLBI
• Contact and FAQs
• NIH Sleep Research Plan
• < Back To Grants and Training

Latest Funding Opportunity Announcements (FOAs)

NOT-OD-24-179 | Released October 11, 2024 Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) Expires January 23, 2026

NOT-OD-24-143 | Released October 09, 2024 Notice of Special Interest (NOSI): Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project Expires September 08, 2027

RFA-NS-25-020 | Released October 08, 2024 HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional) Expires February 07, 2025

Funding Areas

Climate and health - funding opportunities and contacts.

• (ROA): Alliance for Community Engagement- Climate and Health (ACE-CH)
• NIH Climate and Health Scholars Program

COVID-19 - Funding Opportunities and Contacts

• Research Opportunity Announcement (ROA) OTA-21-015I: RECOVER PASC IMMUNOPHENOTYPING CORE LABORATORIES
• Research Opportunity Announcement (ROA) for Clinical Trials for the Prevention and/or Treatment of Post-Acute Sequelae of SARS-CoV-2 infection (PASC)
• Notice of Intent to Publish a Research Opportunity Announcement (ROA) for Clinical Trials for the Prevention and/or Treatment of Post-Acute Sequelae of SARS CoV2 infection (PASC)
• Community Engagement Research Alliance (CEAL) Against COVID-19 Disparities: Consultative Resource
• (ROA): Observational Studies of COVID-19 – A Cohort of Cohorts OTA-2-011A
• (ROA): ACTIV Integration of Host-targeting Therapies for COVID191 OTA-20-011
• (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
• (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
• (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
• (RFA): Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)
• Notice of Expiration of NOT-HL-20-757 "Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)"
• (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
• (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences
• (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials
• (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations
• (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19

Diversity - Funding Opportunities and Contacts

• Diversity, Equity, and Inclusion

Heart - Funding Opportunities and Contacts

• Advanced Technologies and Surgery
• Adult and Pediatric Cardiac Research
• Atherothrombosis and Coronary Artery Disease
• Basic and Early Translational Research
• Clinical Applications and Prevention
• Epidemiology
• Global Cardiovascular Research
• Heart Failure & Arrhythmias
• Heart Development & Structural Diseases
• Heart Failure Data Challenge
• Office of Clinical Research
• Prevention and Population Sciences
• Vascular Biology and Hypertension

Lung - Funding Opportunities and Contacts

• Acute Lung Injury/Critical Care
• Chronic Obstructive Pulmonary Disease (COPD)/Environment
• Cystic Fibrosis
• Genetics, Genomics, and Advanced Technologies
• Interstitial Lung Disease/Fibrosis
• Lung Developmental Biology/Neonatal and Pediatric Diseases
• Lung Response to Pulmonary Infections, Microbiome, AIDS and Tuberculosis
• Lung Transplantation
• Lung Vascular Biology

Blood - Funding Opportunities and Contacts

• Blood Epidemiology and Clinical Therapeutics
• Molecular Cellular and Systems Blood Science
• Translational Blood Science and Resources
• Blood Brain Barrier

Sleep - Funding Opportunities and Contacts

Implementation science - funding opportunities and contacts.

• (ROA) OTA-20-014-C IMPROVE Community Implementation Program (IMPROVE-CIP) Solicitation for Research Coalitions
• Implementation Science Research
• Late-Stage T4 Translation Research
• Global Health

Precision Medicine - Funding Opportunities and Contacts

• Precision Medicine Activities (TOPMed)
• (ROA): BioData Catalyst Data Management Core Program OTA-21-018

Clinical Trials Optimization - Funding Opportunities and Contacts

• Clinical Trials Optimization (Early Phase, Multi-Site, Single-Site, Late Phase)

Small Business - Funding Opportunities and Contacts

• NHLBI Catalyze Program

HIV/AIDS - Funding Opportunities and Contacts

Research and Training Opportunities

New section.

Looking for ways to enrich your medical school experience? Check out our directories of clinical, research, and public health opportunities.

Looking for ways to enrich your medical school experience? Search for fellowships, internships, summer programs, scholarships, and grants currently available in the United States and abroad.

Earn two degrees in four to five years to improve the health of the individuals and communities you serve.

The National Institutes of Health (NIH) Medical Research Scholars Program (MRSP) is a comprehensive, year-long research enrichment program designed to attract the most creative, research-oriented medical, dental, and veterinary students to the intramural campus of the NIH in Bethesda, MD.

Summer programs at the National Institutes of Health (NIH) provide an opportunity to spend a summer working at the NIH side-by-side with some of the leading scientists in the world, in an environment devoted exclusively to biomedical research.

Find Funding Opportunities

  COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements

All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.

Learn more about award types and program directors and managers .

NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!

For more focused results add quotes to indicate parameters. Example format: "search term".

• Find It Fast

Funding Opportunities

• All Funding Opportunities
• What & Who We Fund
• PCORI's Research Funding Process
• What You Need to Know to Apply
• Merit Review

Applicant and Awardee Resources

Research & related projects.

• Explore Our Portfolio
• About Our Research
• On the Path to Impact
• PCORI in the Literature
• Peer Review

Engagement in Research

• Foundational Expectations for Partnerships
• Background on the Foundational Expectations
• Benefits of Engagement in Research
• Real-World Examples by Foundational Expectation
• Frequently Asked Questions
• Promotional Toolkit
• The Value of Engagement in Research
• Engagement Award Program
• Engagement Resources
• Engagement in Health Research Literature Explorer
• Influencing the Culture of Research
• Engage with Us

Implementation of Evidence

• Putting Evidence to Work
• Evidence Updates
• Evidence Synthesis Reports and Interactive Visualizations
• Emerging Topics: Reports and Horizon Scans
• PCORI Stories

Highlights of PCORI-Funded Research Results

Health topics.

• Cardiovascular Disease
• Intellectual and Developmental Disabilities
• Maternal Morbidity and Mortality
• Rare Diseases
• Women's Health
• View All Topics

News & Events

• PCORI News Hub
• View All Events
• 2024 PCORI Annual Meeting: Session Recordings
• The PCORI Strategic Plan
• Our Programs
• Our Vision & Mission
• Financial Statements and Reports
• Board of Governors
• Methodology Committee
• Authorizing Law
• Monitoring and Evaluating Progress
• Advisory Panel Openings
• Advisory Panels FAQs
• Application Review and Selection Process
• Procurement Opportunities
• Provide Input

PCORI funds patient-centered comparative clinical effectiveness research (CER), issuing funding opportunity announcements several times each year. PCORI also funds projects that support CER, such as methodology studies, as well as projects that support engagement in research and dissemination and implementation of PCORI-funded research findings. Use the search/filters below to find available funding opportunities and take advantage of the following resources:

• Standard Due Dates for 2025 Funding Announcement Cycles

View and download resources designed to help prospective applicants and PCORI-funded awardees.

Refine Results:

• Upcoming (8)
• Letters of Intent Under Review (12)
• Applications Under Review (26)
• Closed (191)

Funding Type

• Research (132)
• Engagement in Research (40)
• Health Systems Implementation Initiative (HSII) (3)
• Research Infrastructure (9)
• Supplement (3)

Displaying 1 - 25 of 237 results

What's Happening at PCORI?

The Patient-Centered Outcomes Research Institute sends weekly emails about opportunities to apply for funding, newly funded research studies and engagement projects, results of our funded research, webinars, and other new information posted on our site.

Research Funding Opportunities

Funding opportunities by type.

All active funding opportunities from the National Cancer Institute (NCI).

Requests for Applications (RFA) Find current and recent NCI-supported RFAs that provide funding for various areas of cancer research.

Program Announcements (PA) Find current and recent PAs that invite requests for funding applications to support specific area of cancer research.

NCI and Trans-NIH Initiatives Find current and recent NCI and Trans-NIH Research Project Grants (R01, R21 and R33) that provide funding for specific areas of cancer research.

Requests for Proposals for Contracts Find opportunities for contract funding.

NCI Special Initiatives

Funding Announcements and Notices for COVID-19 When the pandemic began, NCI issued and revised certain existing grants and cooperative agreements to make funds available to study COVID-19. Open funding notices can be found on this page.

Cancer Grand Challenges NCI is partnering with Cancer Research UK to provide multiple rounds of funding for international, interdisciplinary teams to submit approaches addressing one of the open Cancer Grand Challenges. This page shares information on open opportunities and how to apply.

MERIT Award (R37) Early Stage Investigators who have submitted an R01 application within the NCI payline may be eligible for consideration for the Method to Extend Research in Time (MERIT) (R37) Award.

Outstanding Investigator Award (R35) The Outstanding Investigator Award gives investigators the freedom to work on long-term projects with unusual potential in cancer research.

Provocative Questions Program Provocative Questions is an NCI initiative that intends to assemble a list of important questions, or problems that are paradoxes in cancer research that will stimulate research communities to use laboratory, clinical, and population sciences in new, effective, and imaginative ways.

Research Specialist Award (R50) The R50 encourages the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical or population science cancer research program, but not serve as independent investigators.

NCI Funding Opportunities by Research Topic

Artificial Intelligence (AI) AI research is supported by a wide variety of grant and contract programs across NCI.

Basic Biology Research projects in basic cancer biology are supported and coordinated through the Division of Cancer Biology (DCB).

Behavioral Research Behavioral research in cancer prevention and control is supported by the Division of Cancer Control and Population Sciences (DCCPS).

Biorepositories and Tissue Sample Collection Development of biospecimen-related policies and practices affecting NCI Biorepositories is coordinated and managed through the Biorepositories and Biospecimen Research Branch (BBRB).

Cancer Health Disparities Basic cancer research from a health disparities perspective is supported by the Center for Cancer Health Equity (CCHE).

Complementary and Alternative Medicine Research contributing to the advancement of evidence-based complementary and alternative medicine practice is supported by the Office of Cancer Complementary and Alternative Medicine (OCCAM).

Epidemiology and Cancer Control Research in genetic, epidemiologic, behavioral, social, and surveillance cancer research is supported by the Division of Cancer Control and Population Sciences (DCCPS).

HIV /AIDS and Cancer Research on HIV/AIDS pursued throughout the NCI, including programs in AIDS-related cancer are coordinated by the Office of HIV and AIDS Malignancy (OHAM).

Nanotechnology Research supporting the application of nanotechnology to all aspects of cancer research is supported by the NCI Alliance for Nanotechnology in Cancer program that is managed by the Office of Cancer Nanotechnology Research (OCNR).

Physical Sciences-Oncology Research supporting the establishment of scientific teams and individual scientists from the fields of physics, mathematics, chemistry, and engineering to develop novel approaches for cancer research is managed by the Physical Sciences in Oncology Initiative.

Prevention Research that determines and reduces a person’s risk of developing cancer, as well as research to develop and evaluate cancer screening procedures, is supported by the Division of Cancer Prevention (DCP).

Proteomics Research supporting the development of technologies and reagents that will advance our understanding of protein biology in cancer is supported by the Office of Cancer Clinical Proteomics Research (OCCPR).

Small Business and Small Business Technology Transfer Opportunities to increase small business and private sector participation to develop and commercialize novel technologies to prevent, diagnose, and treat cancer are managed by the Small Business Innovation Research and Small Business Technology Transfer (SBIR and STTR) programs.

Statistical Methodology Resources for statisticians are available from StatFund, an online resource that provides information about biostatistical funding opportunities.

Technology Development Research supporting the development of technologies in clinical, laboratory, and epidemiological research are managed by the Innovative Molecular Analysis Technologies Program (IMAT).

Translational Research Research supporting the translation of promising research areas into improved diagnostic and therapeutic interventions for cancer patients is supported by the Division of Cancer Treatment and Diagnosis (DCTD).

Here’s how you know

• U.S. Department of Health and Human Services
• National Institutes of Health

Funding Opportunities

This page provides links to NCCIH-supported funding opportunities in the online NIH Guide for Grants and Contracts. To narrow the list, search using keyword or grant type. You can also view NCCIH Notices below or in the NIH Guide.

View Types of NCCIH Grants

View NIH Glossary & Acronyms List

Visit NIH Guide for Grants and Contracts for all NIH funding opportunities

COVID-19 Funding Opportunities (NIH)

Related Topics

NCCIH Clinical Trial Funding Opportunity Announcements

NIH Loan Repayment Program

An official website of the United States government

Here's how you know

Official websites use .gov A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS A lock ( Lock Locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Communities Advancing Research Equity for Health™ (CARE for Health™)

Funding opportunities.

There are no webinars scheduled at this time  

Technical Assistance Webinar for Integrating Clinical Research into Primary Care Settings through Network Research Hubs - A Pilot (OT2), Tuesday, May 14, 2024 at 12:00 PM ET. Register today!

Technical Assistance Webinar for Integrating Clinical Research into Primary Care Settings through Network Research Hubs - A Pilot (OT2), Wednesday, May 22, 2024 at 12:00 PM ET. Register today!

Current Funding Opportunities

Archived webinars for past opportunities.

Pre-Application Technical Assistance Webinar for Integrating Clinical Research into Primary Care Settings through Network Research Hubs - A Pilot (OT2), was held on Tuesday, May 14, 2024 at 12:00 PM ET. Pre-Application Technical Assistance Webinar  was held on Wednesday, May 22, 2024 at 12:00 PM ET.     Watch the recording online or check out the slides today.

Archived Funding Opportunities

• Research Opportunity Announcement: Integrating Clinical Research into Primary Care Settings through Network Research Hubs – A Pilot (OT2)  

This page last reviewed on August 5, 2024

Scan to visit

• Introduction to Genomics
• Educational Resources
• Policy Issues in Genomics
• The Human Genome Project
• Funding Opportunities
• Funded Programs & Projects
• Division and Program Directors
• Scientific Program Analysts
• Contacts by Research Area
• News & Events
• Research Areas
• Research Investigators
• Research Projects
• Clinical Research
• Data Tools & Resources
• Genomics & Medicine
• Family Health History
• For Patients & Families
• For Health Professionals
• Jobs at NHGRI
• Training at NHGRI
• Funding for Research Training
• Professional Development Programs
• NHGRI Culture
• Social Media
• Broadcast Media
• Image Gallery
• Press Resources
• Organization
• NHGRI Director
• Mission and Vision
• Policies and Guidance
• Institute Advisors
• Strategic Vision
• Leadership Initiatives
• Diversity, Equity, and Inclusion
• Partner with NHGRI
• Staff Search

Research Funding Opportunities

The National Human Genome Research Institute supports research and training and career development opportunities in support of its research mission which is to accelerate scientific and medical breakthroughs that improve human health. We do this by driving cutting-edge research, developing new technologies, and studying the impact of genomics on society.

On this page:

Nhgri funding opportunities, nih-wide parent funding opportunities, nih-wide topic specific funding opportunities, additional resources.

To apprise the community of research areas that support that mission, NHGRI periodically publishes funding opportunities in the  NIH Guide for Grants and Contracts . For your convenience, we have also listed the funding opportunities related to NHGRI on this webpage. NHGRI welcomes innovative investigator-initiated applications and encourages investigators with novel ideas to discuss potential applications with program staff during the concept development stage of the application. If you are considering applying for a Program Announcement with special review (PAR), a Request for Applications (RFA), or an application that exceeds $500K in direct cost in any one year, we encourage you to review the Guidance to Potential Applicants for NHGRI Support .

For how NHGRI will treat new and non-competing applications, see the  NHGRI Funding Policy .

• Notice of Special Interest (NOSI): Small Business Solutions to Assist Genomics-Enabled Learning Health Systems (gLHS): NOT-HG-24-040  
• Notice of Special Interest (NOSI): Small Business Solutions to Enable Regional Genomic Medicine eConsult Services: NOT-HG-24-041  
• Notice of Special Interest (NOSI): Advancing Genomic Technology Development for Research and Clinical Application: NOT-HG-24-036  
• Notice to change the expiration date of PAR-21-254: Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed): NOT-HG-24-033  
• Notice to change the expiration date of PAR-21-255: Investigator Initiated Research in Computational genomics and Data Science (R21 Clinical Trial Not Allowed): NOT-HG-24-034   
• Ethical, Legal, and Social Implications (ELSI) Congress (U13, Clinical Trials Not Allowed) RFA-HG-24-028 Application Due Date(s): November, 19, 2024 Expiration Date: November 20, 2024  
• Notice of Pre-Application Webinar for Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1, Clinical Trial Optional): NOT-HG-24-038  
• Advancing Genomic Medicine Research (R21 Clinical Trial Optional) RFA-HG-23-033 Application Due Date(s): December 01, 2023, July 08, 2024, February 11, 2025 Expiration Date: February 12, 2025  
• SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional) PAR-24-263 Application Due Date(s): December 2, 2024 Expiration Date: December 3, 2024  
• STTR Solutions to Enable Population Genomic Screening (R41/R42 Clinical Trial Optional) PAR-24-262 Application Due Date(s): December 2, 2024 Expiration Date: December 3, 2024  
• Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optional) RFA-HG-24-023 Application Due Date(s): December 2, 2024 Expiration Date: December 3, 2024  
• Population Genomic Screening in Primary Care Cooperative Agreement (U01 - Clinical Trial Required) RFA-HG-24-021 Application Due Date(s): December 2, 2024 Expiration Date: December 3, 2024  
• Population Genomic Screening in Primary Care Coordinating Center (U01 -Clinical Trials Optional) RFA-HG-24-022 Application Due Date(s): December 2, 2024 Expiration Date: December 3, 2024  
• Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) PAR-23-301 Application Due Date(s): February 16, 2024, June 16, 2024, October 16, 2024, February 16, 2025, June 16, 2025, October 16, 2025, February 16, 2026, June 16, 2026 and October 16, 2026 Expiration Date: January 8, 2027  
• Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional) RFA-HG-23-017 Application Due Date(s): November 08, 2023, July 08, 2024, July 08, 2025 (new); July 08, 2024 and July 08, 2025 (renewal) Expiration Date: July 09, 2025  
• Notice of Extension of the First Receipt Date of RFA-HG-23-018: Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial (Clinical Trial Optional): NOT-HG-24-008  
• Notice of Pre-Application Webinar for the Investigator-Initiated Research in Genomics and Health Equity: RFA-HG-23-017 (R01 Clinical Trial Optional) and RFA-HG-23-018 (R21 Clinical Trial Optional): NOT-HG-23-049  
• Notice of Change to NHGRI-specific language in RFA-HG-23-018, Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional): NOT-HG-24-032  
• Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed) PAR-23-184 Application Due Dates: Applications are accepted by continuous receipt and are due by 5:00 PM local time of applicant organization.  Expiration Date: July 09, 2026  
• Notice of Intent to Publish a Funding Opportunity Announcement for Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed) : NOT-HG-23-028  
• Notice of Special Interest: Development and Implementation of Clinical Informatics Tools to Enhance Patients’ Use of Genomic Information NOT-HG-22-011  
• NHGRI’s Analysis, Visualization, and Informatics Lab-space (AnVIL) as an NIH-Designated Data Repository: NOT-HG-24-020
• Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required) PA-24-226 Application Due Date(s): October 12, 2024, February 12, 2025, June 12, 2025, October 12, 2025, February 12, 2026, June 12, 2026, October 12, 2026, February 12, 2027, June 12, 2027 Expiration Date: September 08, 2027  
• Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) PA-24-225 Application Due Date(s): October 12, 2024, February 12, 2025, June 12, 2025, October 12, 2025, February 12, 2026, June 12, 2026, October 12, 2026, February 12, 2027, June 12, 2027 Expiration Date: September 08, 2027  
• Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) PA-24-254 Application Due Date: A change of recipient organization request must be made before the anticipated start date at the new organization and preferably several months in advance. Expiration Date: July 13, 2027  
• Successor-in-Interest (Type 6 Parent Clinical Trial Optional) PA-24-253 Application Due Date: A successor-in-interest request must be made before the anticipated start date at the new organization and preferably several months in advance. Expiration Date: July 18, 2027  
• Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity) PA-23-217 Application Due Date(s): December 08, 2023, April 08, 2024, August 08, 2024​​​​​​, December 08, 2024, April 08, 2025​​​​​​​, August 08, 2025 Expiration Date: September 08, 2025​​​​​​​  
• Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) PAR-21-357 Expiration Date: January 8, 2025  
• Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) PAR-22-060 Expiration Date: January 8, 2025  
• Plans to Promote Safe Environments at Conferences Supported by NIH Grants and Cooperative Agreements NOT-OD-22-074
• Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed) RFA-OD-24-010 Application Due Date(s): December 04,2024, June 04, 2025, December 04, 2025, June 04, 2026, December 04, 2026 Expiration Date: December 05, 2026  
• NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) RFA-OD-24-011 Application Due Date(s): December 04,2024, June 04, 2025, December 04, 2025, June 04, 2026, December 04, 2026 Expiration Date: December 05, 2026  
• NOT-TR-23-026 :  Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3) (Clinical Trial Optional) for Advancing Recruitment through Trial Innovation Network (AR-TIN)  
• PAR-23-124 :  Genomic Community Resources (U24 Clinical Trial Not Allowed) Application Due Date(s): May 25, 2023, September 25, 2023, January 25, 2024, September 25, 2024, January 25, 2025, September 25, 2025, January 25, 2026 Expiration Date: January 26, 2026  
• PAR-23-166 :  Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) Application Due Date(s): July 08, 2024, July 08, 2025, July 08, 2026 Expiration Date: August 08, 2026  
• NOT-OD-23-106 :  Revising the NIH/AHRQ/NIOSH Post-Submission Material Policy  
• PAR-23-138 :  Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)  
• PAR-23-171 : Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed) Application Due Date(s): May 15, 2023, May 15, 2024, May 15, 2025 Expiration Date: May 16, 2025  
• The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) RFA-OD-22-028 Application Due Date(s): December 19, 2022, November 22, 2023; November 22, 2024 Expiration Date: November 23, 2024  
• Notice of Special Interest (NOSI): Research on the Health of Sexual and Gender Minority (SGM) Populations NOT-MD-22-012  
• Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) PAR-22-105 Application Due Date(s): June 15, 2022, October 05, 2022, February 05, 2023, June 05, 2023, June 05, 2023, February 05, 2024, June 05, 2024, October 05, 2024, February 05, 2025 Expiration Date: May 8, 2025  
• Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) PAR-22-106 Application Due Date(s): June 16, 2022, October 16, 2022, February 16, 2023, June 16, 2023, October 16, 2023, February 16, 2024, June 16, 2024, February 16, 2025, June 16, 2025 Expiration Date: September 8, 2025  
• Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) PAR-22-109 Application Due Date(s): June 16, 2022, October 16, 2022, February 16, 2023, June 16, 2023, October 16, 2023, February 16, 2024, June 16, 2024, October 16, 2024 Expiration Date: February 16, 2025  
• Notice of Special Interest (NOSI): Epidemiologic studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed) NOT-HL-23-001  
• Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) PA-21-345 Application Due Dates: Rolling Expiration Date: September 10, 2024  
• Notice of NHGRI's Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)"  NOT-HG-17-004  [grants.nih.gov]

Expired Grant Application Solicitations and Notices

FY2024 NHGRI Funding Policy

Last updated: October 16, 2024

An official website of the United States government

Here’s how you know

Official websites use .gov A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS A lock ( Lock Locked padlock icon ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

• Entire Site
• Research & Funding
• Health Information
• About NIDDK
• Current Funding Opportunities

Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)

Through this I-Corps at NIH program Notice of Funding Opportunity (NOFO), NIH and CDC provide administrative supplement awards to active SBIR (NIH and CDC) and STTR Phase I (NIH only) grantees/awardees. The I-Corps at NIH mission is to empower entrepreneurs in developing and validating a strategic business model through diverse customer discovery in order to meet unmet clinical needs. I-Corps enables and accelerates the transformation of invention to impact SBIR and STTR Phase I awardees in a no-cost extension are eligible as long as, if selected, their no cost extension covers the entire duration of I-Corps at NIH cohort. The program provides three-member project teams with access to instruction and mentoring to accelerate the translation of technologies currently being developed with NIH and CDC SBIR and STTR funding. It is anticipated that outcomes for the I-Corps teams participating in this program will include significantly refined commercialization plans and well-informed pivots in their overall commercialization strategies. Prospective applicants are strongly encouraged to contact Scientific/Research staff for more information about the program before applying.

Funding Opportunity Details

Full Announcement: PA-25-212 Related Notices or Announcements: None

Program Contact: Daniel Gossett, Ph.D.

Open Date: 10/22/2024

Letter of Intent Due Date: Not Applicable

Application Due Date: November 22, 2024, January 31, 2025

Medical Research Council (MRC)

MRC funds research at the forefront of science to prevent illness, develop therapies and improve human health.

MRC content

• Funding, assessment and award management
• Strategy, remit and programmes
• People, skills and fellowships
• Innovation and collaboration
• Investments, impacts and engagement
• Institutes, facilities and resources

MRC impact showcase

MRC funded discovery science underpins gene therapy cures

22 October 2024

UKRI seeks your views in our 2024 stakeholder perception survey

18 October 2024

MRC appoints Deputy Executive Chair

17 October 2024

Driving innovative solutions to improve health and nutrition

View all MRC news

23 October 2024

Improving sustainability in medical research and practice together

28 August 2024

Our new Community Visits programme: what’s that all about then?

View all MRC blog posts

Funding opportunities

Predoctoral clinical research training fellowship.

Apply for funding to undertake a PhD.

Your research can focus on any area of Medical Research Council (MRC)’s remit to improve human health.

• be a registered healthcare professional
• be at an appropriate point in your training to undertake a PhD
• show plans to pursue a research career

Postdoctoral clinical research training fellowship

Apply for funding to reacquire research skills.

• be a PhD graduate working outside of research, usually five or more years ago

View all MRC opportunities

Medical Research Council (MRC) Polaris House, North Star Avenue, Swindon, SN2 1FL

Connect with MRC

Subscribe to ukri emails.

Keep up to date with funding, news and events, and a weekly newsletter.

MRC experimental medicine stage one: applicant webinar

7 November 2024

MRC environmental sustainability seminar: optimising sample storage

25 November 2024

Online and at Bristol (venue to be confirmed)

View all MRC events

This is the website for UKRI: our seven research councils, Research England and Innovate UK. Let us know if you have feedback or would like to help improve our online products and services .

Australian Government Department of Health and Aged Care

Funding opportunity for internationally collaborative clinical trials between Australia and the United Kingdom

A new Australia-United Kingdom (UK) grant opportunity will fund platform trials that address areas of unmet clinical need. This research will improve the lives of people with serious health conditions who have limited options for prevention, diagnosis or treatment.

• X (Twitter)

Platform trials are innovative clinical trials that evaluate multiple interventions through a single study. 

The 2025 Australia-UK Platform Studies in Areas of Unmet Clinical Need grant opportunity is a partnership between:

• the Medical Research Future Fund and the National Health and Medical Research Council (NHMRC), which will provide A$10 million and A$5 million, respectively, for Australian-based activities
• the National Institute for Health and Care Research (NIHR), which will provide an equivalent of A$15 million for UK-based activities.

This joint call for research will harness the UK and Australia’s mutual strengths, ideas, expertise and infrastructure. Applications across all areas of health are welcome. Topics of high interest include, but are not limited to:

• childhood, brain and prostate cancers 
• stroke and traumatic brain injuries 
• neurodegenerative diseases
• cardiometabolic conditions including obesity.

Ms Natasha Ploenges, Chief Executive Officer (CEO) of the  Health and Medical Research Office , said ‘This important collaboration with the UK will fund clinical trials in key areas of unmet clinical need, paving the way for ground breaking treatments that will benefit patients globally.’

Professor Steve Wesselingh, CEO of NHMRC, said ‘International collaborations such as this joint call allow us to explore untapped global talent, and it is exciting to think that the outcomes of these platform trials, where multiple treatments are evaluated simultaneously, could help combat many areas of health and medical research where there is an unmet clinical need.’

Professor Lucy Chappell, CEO of the NIHR, said ‘International efforts such as this partnership drive innovation in health and care, saving and improving lives. Working with our partners in Australia will allow us to maximise our talent, resources and capacity in order to encourage, fund and support life-changing research for the benefit of people across the UK and Australia who face complex health and social care challenges. I look forward to the benefits this partnership will bring for both our countries.’

To learn more about this grant opportunity:

• read the guidelines for the grant opportunity on Australia’s GrantConnect and the NIHR’s webpage  
• register and attend the webinar at 7:00 pm AEDT on 19 November 2024.

Access the NIHR’s Research Awards Lifecycle Management System to submit a joint application with UK research partners to Stage 1 of the grant opportunity.

• Health data and medical research
• Medical Research Future Fund

Is there anything wrong with this page?

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.

• Realting.com
• Krasnodar Krai
• Residential

Residential properties for sale in Krasnodar Krai, Russia

Property types in Krasnodar Krai

Properties features in krasnodar krai, russia.

Krasnodar Krai, Russia GPS Navigator: PLACE STARS

By placing your order, you agree to our Terms of Use

Product Details

Developer info.

• [email protected]
• http://www.placestars.com/contactus
• More apps by this developer

Product features

• On-board maps - no data connection required to browse maps or navigate
• Multi-language voice guidance
• Search by exact address or postcode of your destination
• Fast routing engine allows you to calculate long routes in seconds
• Automatic re-routing – if you miss a turn GPS Navigation App re-routes you automatically

Product description

User data privacy, technical details.

• Access coarse (e.g., Cell-ID, Wi-Fi) location
• Access fine (e.g., GPS) location
• Access storage
• PowerManager WakeLocks to keep processor from sleeping or screen from dimming
• Write to external storage

Customer reviews

• 5 star 4 star 3 star 2 star 1 star 5 star 0% 0% 0% 0% 0% 0%
• 5 star 4 star 3 star 2 star 1 star 4 star 0% 0% 0% 0% 0% 0%
• 5 star 4 star 3 star 2 star 1 star 3 star 0% 0% 0% 0% 0% 0%
• 5 star 4 star 3 star 2 star 1 star 2 star 0% 0% 0% 0% 0% 0%
• 5 star 4 star 3 star 2 star 1 star 1 star 0% 0% 0% 0% 0% 0%

Customer Reviews, including Product Star Ratings help customers to learn more about the product and decide whether it is the right product for them.

To calculate the overall star rating and percentage breakdown by star, we don’t use a simple average. Instead, our system considers things like how recent a review is and if the reviewer bought the item on Amazon. It also analyzed reviews to verify trustworthiness.

No customer reviews

• Amazon Newsletter
• About Amazon
• Accessibility
• Sustainability
• Press Center
• Investor Relations
• Amazon Devices
• Amazon Science
• Sell on Amazon
• Sell apps on Amazon
• Supply to Amazon
• Protect & Build Your Brand
• Become an Affiliate
• Become a Delivery Driver
• Start a Package Delivery Business
• Advertise Your Products
• Self-Publish with Us
• Become an Amazon Hub Partner
• › See More Ways to Make Money
• Amazon Visa
• Amazon Store Card
• Amazon Secured Card
• Amazon Business Card
• Shop with Points
• Credit Card Marketplace
• Reload Your Balance
• Amazon Currency Converter
• Your Account
• Your Orders
• Shipping Rates & Policies
• Amazon Prime
• Returns & Replacements
• Manage Your Content and Devices
• Recalls and Product Safety Alerts
• Registry & Gift List
• Conditions of Use
• Privacy Notice
• Consumer Health Data Privacy Disclosure
• Your Ads Privacy Choices